- Home
- JQC vs INMD Comparison
JQC vs INMD Comparison
Compare JQC & INMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JQC
- INMD
- Stock Information
- Founded
- JQC 2003
- INMD 2008
- Country
- JQC United States
- INMD Israel
- Employees
- JQC N/A
- INMD N/A
- Industry
- JQC Finance Companies
- INMD Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- JQC Finance
- INMD Health Care
- Exchange
- JQC Nasdaq
- INMD Nasdaq
- Market Cap
- JQC 752.6M
- INMD 887.0M
- IPO Year
- JQC N/A
- INMD 2019
- Fundamental
- Price
- JQC $5.51
- INMD $14.11
- Analyst Decision
- JQC
- INMD Hold
- Analyst Count
- JQC 0
- INMD 6
- Target Price
- JQC N/A
- INMD $16.81
- AVG Volume (30 Days)
- JQC 714.6K
- INMD 1.1M
- Earning Date
- JQC 01-01-0001
- INMD 07-30-2025
- Dividend Yield
- JQC 11.13%
- INMD N/A
- EPS Growth
- JQC N/A
- INMD 46.63
- EPS
- JQC N/A
- INMD 2.54
- Revenue
- JQC N/A
- INMD $401,561,000.00
- Revenue This Year
- JQC N/A
- INMD N/A
- Revenue Next Year
- JQC N/A
- INMD $5.41
- P/E Ratio
- JQC N/A
- INMD $5.56
- Revenue Growth
- JQC N/A
- INMD N/A
- 52 Week Low
- JQC $4.82
- INMD $13.14
- 52 Week High
- JQC $5.65
- INMD $19.85
- Technical
- Relative Strength Index (RSI)
- JQC 59.67
- INMD 47.37
- Support Level
- JQC $5.41
- INMD $13.95
- Resistance Level
- JQC $5.55
- INMD $14.41
- Average True Range (ATR)
- JQC 0.03
- INMD 0.39
- MACD
- JQC -0.00
- INMD -0.01
- Stochastic Oscillator
- JQC 56.67
- INMD 46.34
About JQC Nuveen Credit Strategies Income Fund Shares of Beneficial Interest
Nuveen Credit Strategies Income Fund is a diversified closed-end management investment company. Its investment objective is to provide high current income and total return. The fund meets its investment objectives by investing its managed assets in senior secured and second lien loans, and its managed assets across the capital structure of companies (including equity securities) with a primary emphasis on high yield bonds, convertible securities and other forms of income-producing securities.
About INMD InMode Ltd.
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions in the United States. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF and Morpheus8. The majority of its revenue comes from the United States.